Jinchao Chen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Objective: To investigate the effects of growth factors fibroblast-derived extracellular matrix formation in the 3D fiber-deposited polycaprolactone (PCL) scaffold fabricated by 3D printing technique for tissue engineering applications of tunica albuginea. Methods: PCL scaffold was fabricated by 3D bioprinting system. For in vitro cell study, scaffolds were(More)
OBJECTIVE To investigate the predictors of residual tumors at repeat transurethral resection of bladder tumors (re-TURBT) for the patients with T1 bladder cancer and evaluate the effect of the residual tumors on the prognosis of the disease. METHODS We reviewed the clinical data of the patients with T1 bladder cancer who underwent re-TURBT from 2008 to(More)
© Translational Andrology and Urology. All rights reserved. Transl Androl Urol, 2015;4(S1) www.amepc.org/tau CI: 0.92-1.27) for 11 studies conducted in America; 1.36 (95% CI: 0.99-1.86) for 3 studies from Asia. According to the quality of studies, the pooled RRs for high quality and low quality were 1.19 (95% CI: 0.97-1.45), 1.28 (95% CI: 1.03-1.58),(More)
BACKGROUND The aim of the study is to evaluate the role of cytoreductive nephrectomy (CN) with thrombectomy before targeted molecular therapy (TMT) on survival in metastatic renal cell carcinoma (mRCC) with venous tumor thrombus. METHODS We performed a retrospective analysis of 47 patients treated in our center from April 2008 to October 2014. In the(More)
Objective: To determine the impact of variant histologic differentiation of patients with urothelial carcinoma of the bladder on survival after radical cystectomy. Methods: Between 2006 and 2012, 418 consecutive patients who underwent radical cystectomy with lymphadenectomy for urothelial carcinoma of the bladder were included. The patients were divided(More)
© Translational Andrology and Urology. All rights reserved. Transl Androl Urol, 2015;4(S1) www.amepc.org/tau Objective: A novel tumor suppressor gene (TSG) CKLFlike MARVEL transmembrane domain-containing member 3 (CMTM3) is reduced or undetectable in many kinds of cancers and relates tumor malignant features. We detected its role in prostate cancer for(More)
Von Hippel-Lindau (VHL) disease is a rare autosomal dominant cancer syndrome. A phenomenon known as genetic anticipation has been documented in some hereditary cancer syndromes, where it was proved to relate to telomere shortening. Because studies of this phenomenon in VHL disease have been relatively scarce, we investigated anticipation in 18 Chinese VHL(More)
Objective: To compare the prognosis of locally advanced upper tract urothelial carcinoma (UTUC) and bladder tumor (BT) in patients treated with radical surgeries. Methods: We retrospectively reviewed records on 228 consecutive UTUC patients and 174 consecutive BT patients between 2000 and 2012, both with high-stage diseases. Overall and cancer-specific(More)
INTRODUCTION Multilocular cystic clear cell renal cell neoplasm of low malignant potential or multilocular cystic renal cell carcinoma (MCRCC) is a rare distinct subtype of clear cell renal cell carcinoma (RCC). No large series of cases have been reported to date. The present study aimed to characterize the clinical and pathologic features of MCRCC. (More)
  • 1